SS Innovations International (NASDAQ:SSII) Announces Quarterly Earnings Results

SS Innovations International (NASDAQ:SSII) released its quarterly earnings data on Tuesday. The company reported ($0.01) EPS for the quarter, Zacks reports. SS Innovations International had a negative net margin of 28.54% and a negative return on equity of 29.76%. The business had revenue of $14.53 million during the quarter.

SS Innovations International Stock Up 9.7%

Shares of SSII opened at $4.85 on Thursday. SS Innovations International has a 52-week low of $3.02 and a 52-week high of $22.42. The stock has a fifty day simple moving average of $4.80 and a two-hundred day simple moving average of $6.05. The company has a market capitalization of $942.63 million and a PE ratio of -80.83.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SS Innovations International in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Key SS Innovations International News

Here are the key news stories impacting SS Innovations International this week:

• Positive Sentiment: Multiple insiders bought material amounts of stock (CEO Srivastava ~498,753 shares; Director Timothy Adams 300,000 shares; Director Frederic Moll 501,253 shares), totaling ~1.3M shares and ~ $5.2M of purchases — a strong signal of management confidence. SEC filing: Srivastava purchase SEC filing: Adams purchase SEC filing: Moll purchase
• Positive Sentiment: Company reported Q4 and FY‑2025 results highlighting stronger SSi Mantra installations, procedures and revenue growth — supports the growth narrative as the company scales device adoption. GlobeNewswire: Q4/FY2025 results
• Positive Sentiment: Completed a private placement raising approximately $18.6M (5.77M shares, institutional and insider participation) to fund U.S./EU expansion and working capital while awaiting regulatory milestones. The financing reduces near‑term cash risk. GlobeNewswire: Private placement
• Neutral Sentiment: Some institutional investors have added positions recently, which may provide longer‑term support but won’t necessarily reduce short‑term volatility. QuiverQuant: placement/ownership summary
• Negative Sentiment: Reported EPS of ($0.01) for the quarter with a negative net margin (~32%) and negative ROE (~34%) — profitability remains a headwind and could limit multiple expansion until margins improve. GlobeNewswire: Q4/FY2025 results
• Negative Sentiment: The private placement issues 5.77M shares plus unregistered securities/warrants, creating dilution and potential downward pressure on the stock despite the capital raise. GlobeNewswire: Private placement terms
• Negative Sentiment: Company progress depends on regulatory outcomes (FDA 510(k) review and CE marking). Timing and approval risk keep shares volatile until clear regulatory wins occur. GlobeNewswire: regulatory timeline

Insider Activity at SS Innovations International

In other news, CEO Srivastava Sudhir bought 498,753 shares of SS Innovations International stock in a transaction on Friday, March 6th. The shares were bought at an average cost of $4.01 per share, with a total value of $1,999,999.53. Following the completion of the purchase, the chief executive officer directly owned 109,851,767 shares of the company’s stock, valued at approximately $440,505,585.67. This trade represents a 0.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy P. Adams bought 300,000 shares of the firm’s stock in a transaction on Friday, March 6th. The stock was purchased at an average price of $3.99 per share, for a total transaction of $1,197,000.00. Following the completion of the acquisition, the director directly owned 5,331,902 shares in the company, valued at $21,274,288.98. The trade was a 5.96% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders bought 1,300,006 shares of company stock valued at $5,196,999.

Institutional Trading of SS Innovations International

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. purchased a new stake in shares of SS Innovations International during the 4th quarter valued at approximately $68,000. Vontobel Holding Ltd. purchased a new position in SS Innovations International in the fourth quarter worth approximately $116,000. Inspire Investing LLC increased its stake in SS Innovations International by 124.4% during the fourth quarter. Inspire Investing LLC now owns 82,773 shares of the company’s stock worth $470,000 after acquiring an additional 45,886 shares during the last quarter. AlphaCentric Advisors LLC acquired a new stake in SS Innovations International during the fourth quarter worth $284,000. Finally, Geode Capital Management LLC purchased a new stake in SS Innovations International in the second quarter valued at $122,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.